Posted by Michael Wonder on 10 Oct 2016
Life-extending lung cancer drug approved for use in Scotland
10 October 2016 - Scotland has become the first part of the UK to approve a new life-extending treatment for the most common form of advanced lung cancer for use on the NHS.
Rates of lung cancer in Scotland are among the highest in the world and the new treatment helps patients live longer and have a better quality of life.
The SMC approved the new medicine, nivolumab, also known as Opdivo, for use in patients with non-squamous non-small cell lung cancer.
Officials said it can extend the typical eight-month life expectancy by three months.
